What are the major opportunities in the Live Attenuated Polio Vaccine market? What are the strategies for the Live Attenuated Polio Vaccine market?

For detailed insights on the major opportunities and strategies in the Live Attenuated Polio Vaccine market, Read More

How does the Live Attenuated Polio Vaccine market relate to the overall economy and other similar markets?

For detailed insights on Live Attenuated Polio Vaccine's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Live Attenuated Polio Vaccine market growth? SWOT analysis of the Live Attenuated Polio Vaccine market.

For detailed insights on the key dynamics influencing the Live Attenuated Polio Vaccine market growth and SWOT analysis of the Live Attenuated Polio Vaccine industry, Read More

Live Attenuated Polio Vaccine Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Live Attenuated Polio Vaccine Market Report 2026

Name: Live Attenuated Polio Vaccine Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Vaccine Type (Monovalent, Bivalent, Trivalent), By Age Group (Infants (0-1 years), Children (1-5 years)), By End-User (Clinics, Public Health Agencies, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Live Attenuated Polio Vaccine Market Overview

• Live Attenuated Polio Vaccine market size has reached to $1.98 billion in 2025

• Expected to grow to $2.85 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%

• Growth Driver: Expansion Of Immunization Programs Fueling The Growth Of The Market Due To Enhanced Vaccine Accessibility And Disease Prevention

• Market Trend: Regulatory Approvals For Next-Generation Live Attenuated Polio Vaccines

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Live Attenuated Polio Vaccine Market?

The live attenuated polio vaccine (LAPV) is an oral polio vaccine (OPV) that contains a weakened form of the poliovirus that stimulates a strong immune response without causing disease in healthy individuals. It mimics natural infection, offering long-lasting immunity and helping prevent virus transmission within communities.

The main types of vaccines in live attenuated polio vaccine are monovalent, bivalent, and trivalent. A monovalent oral polio vaccine (mOPV) is designed to protect against only one specific type of poliovirus, either type 1, type 2, or type 3. It is administered through oral administration, intramuscular injection, or subcutaneous injection for various age groups, including infants (0-1 years), children (1-5 years), and adults (above 5 years). It caters to various end users, including hospitals, clinics, public health agencies, and other end users.

Live Attenuated Polio Vaccine Market Global Report 2026 Market Report bar graph

What Is The Live Attenuated Polio Vaccine Market Size and Share 2026?

The live attenuated polio vaccine market size has grown strongly in recent years. It will grow from $1.98 billion in 2025 to $2.13 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to global polio eradication initiatives, widespread adoption of oral polio vaccines, strong government-led immunization programs, early success in reducing polio transmission, support from international health organizations.

What Is The Live Attenuated Polio Vaccine Market Growth Forecast?

The live attenuated polio vaccine market size is expected to see strong growth in the next few years. It will grow to $2.85 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to continued eradication efforts in remaining endemic regions, rising focus on outbreak prevention, expansion of vaccination coverage in underserved populations, increased funding for public health immunization programs, growing emphasis on vaccine accessibility and affordability. Major trends in the forecast period include continued use of oral polio vaccines in mass immunization, strong focus on community-level immunity and transmission control, sustained demand in polio-endemic and high-risk regions, integration of lapv in national immunization programs, emphasis on long-lasting immunity in pediatric vaccination.

Book your 30 minutes free consultation with our research experts

Global Live Attenuated Polio Vaccine Market Segmentation

1) By Vaccine Type: Monovalent, Bivalent, Trivalent

2) By Age Group: Infants (0-1 years), Children (1-5 years)

3) By End-User: Clinics, Public Health Agencies, Other End-Users

Subsegments:

1) By Monovalent: mOPV1 For Serotype 1

2) By Bivalent: Type 1, Type 3

3) By Trivalent: Poliovirus Type 1, Poliovirus Type 2, Poliovirus Type 3

What Is The Driver Of The Live Attenuated Polio Vaccine Market?

The expansion of immunization programs is expected to propel the growth of the live attenuated polio vaccine market going forward. Immunization programs refer to organized efforts by governments, health organizations, or other institutions to provide vaccines to populations to prevent the spread of infectious diseases. The expansion of immunization programs is primarily due to increased global awareness of the importance of disease prevention and strong support from governments, international health organizations, and funding bodies. Immunization programs support the live attenuated polio vaccine (LAPV) by ensuring widespread distribution, safe administration, and high coverage to build herd immunity, prevent virus transmission, and aid in global polio eradication. For instance, in May 2025, according to the UK Health Security Agency, a UK-based government agency, during the 2023–2024 season, a school-based programme targeting all children aged 4 to 16 years (Reception to Year 11) in England saw 52.2% of eligible children in Reception to Year 9 (3,498,576 out of 6,708,016) receive the vaccine. This is slightly higher than the 51.9% coverage (3,502,566 out of 6,747,523) recorded in the 2022–2023 season. Therefore, the expansion of immunization programs is driving the growth of the live attenuated polio vaccine industry.

Key Players In The Global Live Attenuated Polio Vaccine Market

Major companies operating in the live attenuated polio vaccine market are Sanofi Pasteur, Serum Institute of India Pvt. Ltd., Biological E Limited, Indian Immunologicals Limited, Bharat Biotech International Limited, Panacea Biotec, Haffkine Biopharmaceutical, Bio Farma, Bilthoven Bio, Vabiotech, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., LG Chem Ltd., Chumakov Federal Scientific Center, Institute of Poliomyelitis and Viral Encephalitides, Statens Serum Institut, Federal State Unitary Enterprise Microgen, Pasteur Institute of Iran, Institut Pasteur de Dakar

Global Live Attenuated Polio Vaccine Market Trends and Insights

Major companies operating in the live attenuated polio vaccine market are focusing on obtaining regulatory approvals to ensure their vaccines meet the safety and efficacy standards required by health authorities globally. Regulatory approvals refer to the formal authorization granted by government health agencies or regulatory bodies, allowing a product, such as a vaccine, to be marketed, sold, and used within a specific region or country. For instance, in July 2024, Biological E, an India-based pharmaceutical and biologics company, received approval from the World Health Organization (WHO) for its novel oral polio vaccine type 2 (nOPV2), a next-generation live, attenuated oral vaccine designed to address the challenges associated with traditional oral polio vaccines. This next-generation vaccine is designed to combat circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks more effectively than its predecessor. nOPV2 is engineered with enhanced genetic stability, reducing the risk of the vaccine virus reverting to a virulent form, which has been a concern with older vaccines.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Live Attenuated Polio Vaccine Market?

In June 2024, SK bioscience, a South Korea-based vaccine and biotech company, acquired IDT Biologika for approximately $244 million. With this acquisition, SK bioscience aims to strengthen its vaccine development and manufacturing leadership, expanding its capabilities and service offerings to drive global health improvements and align with its vision for operational growth and innovation. IDT Biologika is a Germany-based contract development and manufacturing organization for viral vaccines, including live attenuated virus vaccines.

Regional Outlook

North America was the largest region in the live attenuated polio vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Live Attenuated Polio Vaccine Market?

The live attenuated polio vaccine market consists of sales of monovalent oral polio vaccine (mOPV), bivalent oral polio vaccine (bOPV), novel oral polio vaccine, and trivalent oral polio vaccine (tOPV). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Live Attenuated Polio Vaccine Market Report 2026?

The live attenuated polio vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the live attenuated polio vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Live Attenuated Polio Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.13 billion
Revenue Forecast In 2035	$2.85 billion
Growth Rate	CAGR of 7.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Vaccine Type, Age Group, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Sanofi Pasteur, Serum Institute of India Pvt. Ltd., Biological E Limited, Indian Immunologicals Limited, Bharat Biotech International Limited, Panacea Biotec, Haffkine Biopharmaceutical, Bio Farma, Bilthoven Bio, Vabiotech, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., LG Chem Ltd., Chumakov Federal Scientific Center, Institute of Poliomyelitis and Viral Encephalitides, Statens Serum Institut, Federal State Unitary Enterprise Microgen, Pasteur Institute of Iran, Institut Pasteur de Dakar
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Live Attenuated Polio Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Live Attenuated Polio Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Live Attenuated Polio Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Live Attenuated Polio Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Continued Use Of Oral Polio Vaccines In Mass Immunization

4.2.2 Strong Focus On Community-Level Immunity And Transmission Control

4.2.3 Sustained Demand In Polio-Endemic And High-Risk Regions

4.2.4 Integration Of Lapv In National Immunization Programs

4.2.5 Emphasis On Long-Lasting Immunity In Pediatric Vaccination

5. Live Attenuated Polio Vaccine Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Public Health Agencies

5.4 Immunization Centers

5.5 Non-Governmental Health Organizations

6. Live Attenuated Polio Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Live Attenuated Polio Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Live Attenuated Polio Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Live Attenuated Polio Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Live Attenuated Polio Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Live Attenuated Polio Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Live Attenuated Polio Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Live Attenuated Polio Vaccine Market Segmentation

9.1. Global Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monovalent, Bivalent, Trivalent

9.2. Global Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infants (0-1 years), Children (1-5 years)

9.3. Global Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinics, Public Health Agencies, Other End-Users

9.4. Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

mOPV1 For Serotype 1

9.5. Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Bivalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Type 1, Type 3

9.6. Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Trivalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Poliovirus Type 1, Poliovirus Type 2, Poliovirus Type 3

10. Live Attenuated Polio Vaccine Market Regional And Country Analysis

10.1. Global Live Attenuated Polio Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Live Attenuated Polio Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Live Attenuated Polio Vaccine Market

11.1. Asia-Pacific Live Attenuated Polio Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Live Attenuated Polio Vaccine Market

12.1. China Live Attenuated Polio Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Live Attenuated Polio Vaccine Market

13.1. India Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Live Attenuated Polio Vaccine Market

14.1. Japan Live Attenuated Polio Vaccine Market Overview

14.2. Japan Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Live Attenuated Polio Vaccine Market

15.1. Australia Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Live Attenuated Polio Vaccine Market

16.1. Indonesia Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Live Attenuated Polio Vaccine Market

17.1. South Korea Live Attenuated Polio Vaccine Market Overview

17.2. South Korea Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Live Attenuated Polio Vaccine Market

18.1. Taiwan Live Attenuated Polio Vaccine Market Overview

18.2. Taiwan Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Live Attenuated Polio Vaccine Market

19.1. South East Asia Live Attenuated Polio Vaccine Market Overview

19.2. South East Asia Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Live Attenuated Polio Vaccine Market

20.1. Western Europe Live Attenuated Polio Vaccine Market Overview

20.2. Western Europe Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Live Attenuated Polio Vaccine Market

21.1. UK Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Live Attenuated Polio Vaccine Market

22.1. Germany Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Live Attenuated Polio Vaccine Market

23.1. France Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Live Attenuated Polio Vaccine Market

24.1. Italy Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Live Attenuated Polio Vaccine Market

25.1. Spain Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Live Attenuated Polio Vaccine Market

26.1. Eastern Europe Live Attenuated Polio Vaccine Market Overview

26.2. Eastern Europe Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Live Attenuated Polio Vaccine Market

27.1. Russia Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Live Attenuated Polio Vaccine Market

28.1. North America Live Attenuated Polio Vaccine Market Overview

28.2. North America Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Live Attenuated Polio Vaccine Market

29.1. USA Live Attenuated Polio Vaccine Market Overview

29.2. USA Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Live Attenuated Polio Vaccine Market

30.1. Canada Live Attenuated Polio Vaccine Market Overview

30.2. Canada Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Live Attenuated Polio Vaccine Market

31.1. South America Live Attenuated Polio Vaccine Market Overview

31.2. South America Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Live Attenuated Polio Vaccine Market

32.1. Brazil Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Live Attenuated Polio Vaccine Market

33.1. Middle East Live Attenuated Polio Vaccine Market Overview

33.2. Middle East Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Live Attenuated Polio Vaccine Market

34.1. Africa Live Attenuated Polio Vaccine Market Overview

34.2. Africa Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Segmentation By Age Group, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Live Attenuated Polio Vaccine Market Regulatory and Investment Landscape

36. Live Attenuated Polio Vaccine Market Competitive Landscape And Company Profiles

36.1. Live Attenuated Polio Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Live Attenuated Polio Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Live Attenuated Polio Vaccine Market Company Profiles

36.3.1. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Serum Institute of India Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Biological E Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Indian Immunologicals Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bharat Biotech International Limited Overview, Products and Services, Strategy and Financial Analysis

37. Live Attenuated Polio Vaccine Market Other Major And Innovative Companies

Panacea Biotec, Haffkine Biopharmaceutical, Bio Farma, Bilthoven Bio, Vabiotech, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., LG Chem Ltd., Chumakov Federal Scientific Center, Institute of Poliomyelitis and Viral Encephalitides, Statens Serum Institut, Federal State Unitary Enterprise Microgen, Pasteur Institute of Iran, Institut Pasteur de Dakar

38. Global Live Attenuated Polio Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Live Attenuated Polio Vaccine Market

40. Live Attenuated Polio Vaccine Market High Potential Countries, Segments and Strategies

40.1 Live Attenuated Polio Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Live Attenuated Polio Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Live Attenuated Polio Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Live Attenuated Polio Vaccine Market, Overview Of Key Products - Product Examples

Table 2: Global Live Attenuated Polio Vaccine Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Live Attenuated Polio Vaccine Market, Supply Chain Analysis

Table 4: Global Live Attenuated Polio Vaccine Market, Major Raw Material Providers

Table 5: Global Live Attenuated Polio Vaccine Market, Major Resource Providers

Table 6: Global Live Attenuated Polio Vaccine Market, Major Manufacturers (Suppliers)

Table 7: Global Live Attenuated Polio Vaccine Market, Major Distributors And Channel Partners

Table 8: Global Live Attenuated Polio Vaccine Market, Key Technologies & Future Trends

Table 9: Global Live Attenuated Polio Vaccine Market, Major Trends

Table 10: Global Live Attenuated Polio Vaccine Market, Major End Users

Table 11: Global Live Attenuated Polio Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Live Attenuated Polio Vaccine Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Live Attenuated Polio Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Live Attenuated Polio Vaccine Market - TAM, US$ Billion, 2025

Table 15: Global Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Bivalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Trivalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Live Attenuated Polio Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Live Attenuated Polio Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Live Attenuated Polio Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Live Attenuated Polio Vaccine Market - Company Scoring Matrix

Table 97: Sanofi Pasteur Financial Performance

Table 98: Serum Institute of India Pvt. Ltd. Financial Performance

Table 99: Biological E Limited Financial Performance

Table 100: Indian Immunologicals Limited Financial Performance

Table 101: Bharat Biotech International Limited Financial Performance

Table 102: Global Live Attenuated Polio Vaccine Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Live Attenuated Polio Vaccine Market, Competitive Dashboard

Table 104: Global Live Attenuated Polio Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Live Attenuated Polio Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030

Table 106: Global, Live Attenuated Polio Vaccine Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Table 107: Global, Live Attenuated Polio Vaccine Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

List Of Figures

Figure 1: Global Live Attenuated Polio Vaccine Market, Overview Of Key Products - Product Examples

Figure 2: Global Live Attenuated Polio Vaccine Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Live Attenuated Polio Vaccine Market, Supply Chain Analysis

Figure 4: Global Live Attenuated Polio Vaccine Market, Major Raw Material Providers

Figure 5: Global Live Attenuated Polio Vaccine Market, Major Resource Providers

Figure 6: Global Live Attenuated Polio Vaccine Market, Major Manufacturers (Suppliers)

Figure 7: Global Live Attenuated Polio Vaccine Market, Major Distributors And Channel Partners

Figure 8: Global Live Attenuated Polio Vaccine Market, Key Technologies & Future Trends

Figure 9: Global Live Attenuated Polio Vaccine Market, Major Trends

Figure 10: Global Live Attenuated Polio Vaccine Market, Major End Users

Figure 11: Global Live Attenuated Polio Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Live Attenuated Polio Vaccine Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Live Attenuated Polio Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Live Attenuated Polio Vaccine Market - TAM, US$ Billion, 2025

Figure 15: Global Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Monovalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Bivalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Live Attenuated Polio Vaccine Market, Sub-Segmentation Of Trivalent, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Live Attenuated Polio Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Live Attenuated Polio Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Live Attenuated Polio Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Live Attenuated Polio Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Live Attenuated Polio Vaccine Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Live Attenuated Polio Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Live Attenuated Polio Vaccine Market - Company Scoring Matrix

Figure 97: Sanofi Pasteur Financial Performance

Figure 98: Serum Institute of India Pvt. Ltd. Financial Performance

Figure 99: Biological E Limited Financial Performance

Figure 100: Indian Immunologicals Limited Financial Performance

Figure 101: Bharat Biotech International Limited Financial Performance

Figure 102: Global Live Attenuated Polio Vaccine Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Live Attenuated Polio Vaccine Market, Competitive Dashboard

Figure 104: Global Live Attenuated Polio Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Live Attenuated Polio Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030

Figure 106: Global, Live Attenuated Polio Vaccine Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Figure 107: Global, Live Attenuated Polio Vaccine Market Size Gain ($ Billion), Segmentation By End-User, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Industry Trends Show Locum Tenens Staffing Market Set to Expand at 11.6% CAGR Until 2029

In-Depth Lung Cancer Surgery Market Report: Business Trends, Growth Factors, and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Vaccine Delivery Devices Market Report 2026 - Global Outlook – By Type Of Device (Needle Free Injection Systems, Oral Delivery Systems, Nasal Delivery Systems, Jet Injectors, Microneedle Patches And Microinjectors), By R...

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Vaccine Adjuvants Market Report 2026 - Global Outlook – By Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types), By Route of Application (Human Vaccine...

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Conjugate Vaccine Market Report 2026 - Global Outlook – By Product Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccine), By Pathogen (Bacterial, Viral), By Disease Indication (Pneumococcal, Influenza, Meni...

Inactivated Vaccines Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine), By Method Of Inactivation (Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inacti...

Frequently Asked Questions

How big is the Live Attenuated Polio Vaccine Market?

The Live Attenuated Polio Vaccine market was valued at $1.98 billion in 2025, increased to $2.13 billion in 2026, and is projected to reach $2.85 billion by 2030.

What is the Live Attenuated Polio Vaccine market growth?

The global Live Attenuated Polio Vaccine market is expected to grow at a CAGR of 7.6% from 2026 to 2035 to reach $2.85 billion by 2035.

Who are the key players in Live Attenuated Polio Vaccine market?

Some Key Players in the Live Attenuated Polio Vaccine market Include, Sanofi Pasteur, Serum Institute of India Pvt. Ltd., Biological E Limited, Indian Immunologicals Limited, Bharat Biotech International Limited, Panacea Biotec, Haffkine Biopharmaceutical, Bio Farma, Bilthoven Bio, Vabiotech, Sinovac Biotech Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., LG Chem Ltd., Chumakov Federal Scientific Center, Institute of Poliomyelitis and Viral Encephalitides, Statens Serum Institut, Federal State Unitary Enterprise Microgen, Pasteur Institute of Iran, Institut Pasteur de Dakar .

What is the anticipated growth trend for the Live Attenuated Polio Vaccine market?

Major trend in this market includes: Regulatory Approvals For Next-Generation Live Attenuated Polio Vaccines. For further insights on this market. request a sample here

Which region has the most growth potential in the Live Attenuated Polio Vaccine market?

North America was the largest region in the live attenuated polio vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the live attenuated polio vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.